ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 32937 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 32937; 2) Community: the network communities that were significantly associated with the response to NSC 32937; 3) Molecule: the relationships between components within communities and NSC 32937; 4) MDR: the compounds that were significantly associated with the NSC 32937.

NSC Compound Enrichment Correlation
NSC 716503 Null 0.0434721470609156 -0.073382765
NSC 718781 Erlotinib hydrochloride 0.0434721470609156 -0.29472633
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0434721470609156 0.076732219
NSC 734561 6-(3-chloropropyl)-6,11-dihydro-2,3-dimethoxy-5,11-dioxo-5H- indeno[1,2-c]isoquinoline-9-carbonitrile 0.0434721470609156 0.047897748
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0434721470609156 0.36008566
NSC 752346 Null 0.0434721470609156 0.23322024
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0434721470609156 0.026710246
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0434721470609156 0.053201226
NSC 755442 Null 0.0434721470609156 0.064036919
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.0434721470609156 0.18538241
Total:126  Current:102    [First] [Prev] [Next] [Last]